Tag Archives: success

Alexion runs toward big Ultomiris goals with early Soliris switching success

Alexion has big goals for Soliris follow-up Ultomiris in paroxysmal nocturnal hemoglobinuria (PNH), and wooing patients over from predecessor Soliris is key. But so far, executives say, those aims are right on track. As of the end of January—the first full month of the newcomer’s rollout after its Dec. 27 approval—Alexion had switched about 5%… Read More »